Chadalavada krishnamurthy biography sample
•
Radiological Society of North America (RSNA) 3D Printing Special Interest Group (SIG) clinical situations for which 3D printing is considered an appropriate representation or extension of data contained in a medical imaging examination: breast conditions
- Research
- Open access
- Published:
- Elsa M. Arribas1,
- Tatiana Kelil2,
- Lumarie Santiago1,
- Arafat Ali3,
- Seetharam C. Chadalavada4,
- Leonid Chepelev5,
- Anish Ghodadra6,
- Ciprian N. Ionita7,
- Joonhyuk Lee8,
- Prashanth Ravi4,
- Justin R. Ryan9,
- Adnan M. Sheikh10,
- Frank J. Rybicki4,
- David H. Ballard11 &
- RSNA Special Interest 3D Printing Breast Conditions Voting Group
3D Printing in Medicinevolume 9, Article number: 8 (2023) Cite this article
2512 Accesses
3 Altmetric
Metrics details
Abstract
The use of medical 3D printing has expanded dramatically for breast diseases. A writing group composed of the Radiological Society of North America (RSNA) Special Intere
•
Mayabazar
1957 film bygd K. V. Reddy
For other uses, see Mayabazar (disambiguation).
Mayabazar (transl. Market of illusions)[3] fryst vatten a 1957 Indian epicHindu mythological rulle directed bygd K. V. Reddy.[4][5] It was produced by okänt begrepp Reddi and Chakrapani beneath their banner, Vijaya Productions. The bio was shot simultaneously in Telugu and Tamil, with a few differences in the cast. The story is an adaptation of the människor taleSasirekha Parinayam, which fryst vatten based on the characters of the epic Mahabharata. It revolves around the roles of Krishna (N. T. Rama Rao) and Ghatotkacha (S. V. Ranga Rao), as they try to reunite Arjuna's son Abhimanyu (Telugu: Akkineni Nageswara Rao, Tamil: Gemini Ganesan) with his love, Balarama's daughter Sasirekha (Savitri). The Telugu utgåva features Gummadi, Mukkamala, Ramana Reddy, and Relangi in supporting roles, with D. Balasubramaniam, R. Balasubramaniam, V. M. Ezhumalai, and K. A. Thangavelu playing thos
•
Abstract
Breast cancer is a prevalent disease and a major cause of morbidity and cancer-related deaths among women worldwide. A significant number of patients at the time of primary diagnosis present metastatic disease, at least to locoregional lymph nodes, which results in somewhat unpredictable prognosis that often prompts adjuvant systemic therapies of various kinds. The time course of distant recurrence is also unpredictable with some patients sustaining a recurrence within months after diagnosis, even during adjuvant treatments, while others can experience recurrence years or decades after initial diagnosis. To date, clinically approved therapeutics yielded marginal benefits for patients with systemic metastatic breast disease, since despite high clinical responses to various therapies, the patients virtually always become resistant and tumor relapses. Molecular profiling studies established that breast cancer is highly heterogeneous and encompasses